Answers are grounded in this paper and cite their sources.
Thalidomide is active against advanced myeloma. It can induce marked and durable responses in some patients with multiple myeloma, including those who relapse after high-dose chemotherapy.
No takes yet. Share an insight, caveat, or question.
Singhal et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: